ABG Analytics logo
 

Bristol-Myers Squibb Co (NYSE: BMY)

DRUGS - Drug Manufacturers - Major
Sector: Health Care
Stock price data as of 12/01/2023
Closing price: 50.10
Support price level: N/A
Resistance price level: $53.63
Relative strength index (14-day RSI) 47.1
Beta 0.32
  • With a -37.6 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.

  • The price of this low-beta stock is expected to increase by 0.32% for every 1% increase in the S&P-500.

  • Volatility is forecast to fall over the next month.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$48.48 $81.13 6.4%
200 day 50 day 20 day 10 day
$62.38 $53.76 $50.40 $49.35
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
23.4% 29.1% 25.2% 24.1%
There is an estimated 5% probability that the stock price of Bristol-Myers Squibb Co will fall by more than:
  • 6.9% in the next week.

  • 13.6% in the next month.

  • 37.5% in the next year.